Jennifer Shi

Jennifer Shi has a diverse and extensive work experience in the field of clinical research and operations. Their career began in 1996 as a Clinical Research Associate at PPD and later joined Inveresk Research in the same role. In 1999, they joined IQVIA as an Associate Manager/Clinical Research Scientist. In 2002, they moved to GSK, where they held various roles, including Lead/Senior Study Manager and Vendor Operations Lead. Jennifer joined Atox Bio in 2016 as the Director of Clinical Operations. Jennifer then worked at Immunovant as the Senior Director of Clinical Operations and later transitioned to the role of Director of Clinical Operations at Roivant. In 2019, they joined Biogen as the Clinical Operations Program Lead. Jennifer continued to progress in their career, joining Taysha Gene Therapies in 2021 as the Director of Trial Management. Their most recent role is the Director of Clinical Operations at Alector, where they started in 2022. Jennifer Shi's work experience showcases their expertise in clinical operations and their ability to assume leadership positions in the industry.

Jennifer Shi has a Bachelor of Science degree in Clinical Laboratory Science from the University of North Carolina at Chapel Hill. Additionally, they also have a Bachelor of Science degree in Biology from the same university. No start or end dates are provided for these educational programs.